facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita opens new research site in Poznan

      Krakow, Poland – 4 February 2016 – Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, has signed a contract for the lease of laboratory space in Poznan, Poland. The new site will be located at in the Wielkopolska…

    Read More...

  • Selvita will present at the 18th Annual BIO CEO & Investor Conference 2016

    Krakow, 1 February 2016 - Selvita S.A. (WSE: SLV), the largest drug discovery company in Central and Eastern Europe, today announced that Pawel Przewiezlikowski, Chief Executive Officer of the company, will present at the upcoming 18th Annual BIO CEO…

    Read More...

  • Selvita joins the European network of laboratories EU NETVAL

    Krakow, December 15, 2015 - Selvita, the largest drug discovery company in Central and Eastern Europe, announced today that its Cell and Molecular Biology Laboratory has been incorporated into the European network of laboratories EU NETVAL (European…

    Read More...